Language: Italian
Published by Il Pensiero Scientifico Editore, 1979
ISBN 10: 887002038X ISBN 13: 9788870020380
Seller: Libro Co. Italia Srl, San Casciano Val di Pesa, FI, Italy
Brossura. Condition: new. Roma, 1979; br., pp. 394, ill. Libro.
Seller: libreriauniversitaria.it, Occhiobello, RO, Italy
Condition: NEW.
Condition: New.
Condition: As New. Unread book in perfect condition.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: New.
Paperback. Condition: Brand New. 715 pages. 10.50x8.25x2.00 inches. In Stock.
Language: English
Published by Elsevier Science Publishing Co Inc, San Diego, 2017
ISBN 10: 0128094001 ISBN 13: 9780128094006
Seller: Grand Eagle Retail, Bensenville, IL, U.S.A.
Hardcover. Condition: new. Hardcover. Adverse Events and Oncotargeted Kinase Inhibitors Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: As New. Unread book in perfect condition.
Condition: New.
Gebunden. Condition: New.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
£ 189.04
Quantity: Over 20 available
Add to basketCondition: New. In.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
£ 189.04
Quantity: Over 20 available
Add to basketCondition: New. In.
Seller: Libro Co. Italia Srl, San Casciano Val di Pesa, FI, Italy
Rilegato. Condition: new. Milano, 2013; ril., cm 16x24. Libro.
hardcover. Condition: New. Special order direct from the distributor.
Seller: preigu, Osnabrück, Germany
Taschenbuch. Condition: Neu. Adverse Events with Biomedicines | Prevention Through Understanding | Giuseppe Tridente | Taschenbuch | xxx | Englisch | 2017 | Springer | EAN 9788847058484 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
First Edition
Condition: New. Num Pages: 672 pages. BIC Classification: MMG. Category: (P) Professional & Vocational. Dimension: 276 x 216. . . 2017. 1st Edition. hardcover. . . . .
Language: English
Published by Springer Milan, Springer Milan, 2017
ISBN 10: 8847058481 ISBN 13: 9788847058484
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This monograph gathers and evaluates data on adverse events (AEs) associated specifically with those 'biomedicines' - monoclonal antibodies, fusion proteins, and cytokines - that have recently entered therapeutic use in humans. All AEs observed when using each member of this new drug class are covered, with a view to improving understanding of pathogenesis, facilitating prevention, monitoring, and control, and contributing to the development of better drugs that provide benefits while minimizing risk. Further aspects here examined include the role of drug mechanisms of action and immunogenicity in relation to AEs outcome and induction of systemic syndromes. Additional data on AEs in off-label treatments are also considered.Electronic data sheets, downloadable from Springer Extra Materials platform, include more detailed safety data as well as additional basic information on product characteristics, pre- and post-marketing AEs classified according to frequency, and system/organ targeting. Data on excipients and selected information on drug interactions and associations are also provided. Adverse Events with Biomedicines: Prevention Through Understanding will serve as a detailed, practical guideline to this important new area, which demands the attention of clinicians, immunologists, oncologists, allergologists, public health professionals, and drug companies.
Language: English
Published by Springer Milan, Springer Milan, 2013
ISBN 10: 8847053129 ISBN 13: 9788847053120
Seller: AHA-BUCH GmbH, Einbeck, Germany
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This monograph gathers and evaluates data on adverse events (AEs) associated specifically with those 'biomedicines' - monoclonal antibodies, fusion proteins, and cytokines - that have recently entered therapeutic use in humans. All AEs observed when using each member of this new drug class are covered, with a view to improving understanding of pathogenesis, facilitating prevention, monitoring, and control, and contributing to the development of better drugs that provide benefits while minimizing risk. Further aspects here examined include the role of drug mechanisms of action and immunogenicity in relation to AEs outcome and induction of systemic syndromes. Additional data on AEs in off-label treatments are also considered.Electronic data sheets, downloadable from Springer Extra Materials platform, include more detailed safety data as well as additional basic information on product characteristics, pre- and post-marketing AEs classified according to frequency, and system/organ targeting. Data on excipients and selected information on drug interactions and associations are also provided. Adverse Events with Biomedicines: Prevention Through Understanding will serve as a detailed, practical guideline to this important new area, which demands the attention of clinicians, immunologists, oncologists, allergologists, public health professionals, and drug companies.
Paperback. Condition: Brand New. 715 pages. 10.50x8.25x2.00 inches. In Stock.
Condition: New. Num Pages: 672 pages. BIC Classification: MMG. Category: (P) Professional & Vocational. Dimension: 276 x 216. . . 2017. 1st Edition. hardcover. . . . . Books ship from the US and Ireland.
Seller: Revaluation Books, Exeter, United Kingdom
Hardcover. Condition: Brand New. 2014 edition. 633 pages. 9.25x6.25x1.50 inches. In Stock.
Seller: Revaluation Books, Exeter, United Kingdom
Paperback. Condition: Brand New. reprint edition. 664 pages. 9.00x6.00x1.25 inches. In Stock.
Language: English
Published by Elsevier Science Publishing Co Inc, San Diego, 2017
ISBN 10: 0128094001 ISBN 13: 9780128094006
Seller: AussieBookSeller, Truganina, VIC, Australia
Hardcover. Condition: new. Hardcover. Adverse Events and Oncotargeted Kinase Inhibitors Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
Seller: Mispah books, Redhill, SURRE, United Kingdom
Paperback. Condition: Like New. Like New. book.
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New. pp. 633.
Seller: Brook Bookstore On Demand, Napoli, NA, Italy
Condition: new. Questo è un articolo print on demand.
Seller: Brook Bookstore On Demand, Napoli, NA, Italy
Condition: new. Questo è un articolo print on demand.
Condition: new. Questo è un articolo print on demand.
Language: English
Published by Springer Milan, Springer Milan Dez 2013, 2013
ISBN 10: 8847053129 ISBN 13: 9788847053120
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This monograph gathers and evaluates data on adverse events (AEs) associated specifically with those 'biomedicines' - monoclonal antibodies, fusion proteins, and cytokines - that have recently entered therapeutic use in humans. All AEs observed when using each member of this new drug class are covered, with a view to improving understanding of pathogenesis, facilitating prevention, monitoring, and control, and contributing to the development of better drugs that provide benefits while minimizing risk. Further aspects here examined include the role of drug mechanisms of action and immunogenicity in relation to AEs outcome and induction of systemic syndromes. Additional data on AEs in off-label treatments are also considered.Electronic data sheets, downloadable from Springer Extra Materials platform, include more detailed safety data as well as additional basic information on product characteristics, pre- and post-marketing AEs classified according to frequency, and system/organ targeting. Data on excipients and selected information on drug interactions and associations are also provided. Adverse Events with Biomedicines: Prevention Through Understanding will serve as a detailed, practical guideline to this important new area, which demands the attention of clinicians, immunologists, oncologists, allergologists, public health professionals, and drug companies. 664 pp. Englisch.
Language: English
Published by Springer Milan Mai 2017, 2017
ISBN 10: 8847058481 ISBN 13: 9788847058484
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This monograph gathers and evaluates data on adverse events (AEs) associated specifically with those 'biomedicines' - monoclonal antibodies, fusion proteins, and cytokines - that have recently entered therapeutic use in humans. All AEs observed when using each member of this new drug class are covered, with a view to improving understanding of pathogenesis, facilitating prevention, monitoring, and control, and contributing to the development of better drugs that provide benefits while minimizing risk. Further aspects here examined include the role of drug mechanisms of action and immunogenicity in relation to AEs outcome and induction of systemic syndromes. Additional data on AEs in off-label treatments are also considered.Electronic data sheets, downloadable from Springer Extra Materials platform, include more detailed safety data as well as additional basic information on product characteristics, pre- and post-marketing AEs classified according to frequency, and system/organ targeting. Data on excipients and selected information on drug interactions and associations are also provided. Adverse Events with Biomedicines: Prevention Through Understanding will serve as a detailed, practical guideline to this important new area, which demands the attention of clinicians, immunologists, oncologists, allergologists, public health professionals, and drug companies. 664 pp. Englisch.